Is an anticholinergic agent superior to a β2-agonist in improving dyspnea and exercise limitation in COPD?

S. A. Blosser, S. L. Maxwell, M. K. Reeves-Hoche, A. R. Localio, C. W. Zwillich

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'Is an anticholinergic agent superior to a β2-agonist in improving dyspnea and exercise limitation in COPD?'. Together they form a unique fingerprint.

Medicine & Life Sciences